Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
- PMID: 17141510
- DOI: 10.1016/j.nbd.2006.10.007
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
Abstract
Oxidative stress and protein aggregation are biochemical hallmarks of Parkinson's disease (PD), a frequent sporadic late-onset degenerative disorder particularly of dopaminergic neurons in the substantia nigra, resulting in impaired spontaneous movement. PARK6 is a rare autosomal-recessively inherited disorder, mimicking the clinical picture of PD with earlier onset and slower progression. Genetic data demonstrated PARK6 to be caused by mutations in the protein PINK1, which is localized to mitochondria and has a serine-threonine kinase domain. To study the effect of PINK1 mutations on oxidative stress, we used primary fibroblasts and immortalized lymphoblasts from three patients homozygous for G309D-PINK1. Oxidative stress was evident from increases in lipid peroxidation and in antioxidant defenses by mitochondrial superoxide dismutase and glutathione. Elevated levels of glutathione reductase and glutathione-S-transferase were also observed. As a putative cause of oxidation, a mild decrease in complex I activity and a trend to superoxide elevation were detectable. These data indicate that PINK1 function is critical to prevent oxidative damage and that peripheral cells may be useful for studies of progression and therapy of PARK6.
Similar articles
-
Parkinson patient fibroblasts show increased alpha-synuclein expression.Exp Neurol. 2008 Aug;212(2):307-13. doi: 10.1016/j.expneurol.2008.04.004. Epub 2008 Apr 16. Exp Neurol. 2008. PMID: 18511044
-
Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population.Parkinsonism Relat Disord. 2008;14(1):52-7. doi: 10.1016/j.parkreldis.2007.06.009. Epub 2007 Nov 26. Parkinsonism Relat Disord. 2008. PMID: 18032086
-
Sleep quality in a family with hereditary parkinsonism (PARK6).Sleep Med. 2008 Aug;9(6):684-8. doi: 10.1016/j.sleep.2007.07.004. Epub 2007 Sep 4. Sleep Med. 2008. PMID: 17766179
-
Genetic mutations and functions of PINK1.Trends Pharmacol Sci. 2011 Oct;32(10):573-80. doi: 10.1016/j.tips.2011.06.001. Epub 2011 Jul 23. Trends Pharmacol Sci. 2011. PMID: 21784538 Review.
-
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.Apoptosis. 2010 Nov;15(11):1336-53. doi: 10.1007/s10495-010-0465-0. Apoptosis. 2010. PMID: 20131004 Review.
Cited by
-
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.EMBO J. 2012 Jun 26;31(14):3038-62. doi: 10.1038/emboj.2012.170. EMBO J. 2012. PMID: 22735187 Free PMC article. Review.
-
PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane.Cell Metab. 2015 Jan 6;21(1):95-108. doi: 10.1016/j.cmet.2014.12.007. Cell Metab. 2015. PMID: 25565208 Free PMC article.
-
Systematic Surveys of Iron Homeostasis Mechanisms Reveal Ferritin Superfamily and Nucleotide Surveillance Regulation to be Modified by PINK1 Absence.Cells. 2020 Oct 2;9(10):2229. doi: 10.3390/cells9102229. Cells. 2020. PMID: 33023155 Free PMC article.
-
The role of oxidative stress in Parkinson's disease.J Parkinsons Dis. 2013;3(4):461-91. doi: 10.3233/JPD-130230. J Parkinsons Dis. 2013. PMID: 24252804 Free PMC article. Review.
-
Searching for Potential Lipid Biomarkers of Parkinson's Disease in Parkin-Mutant Human Skin Fibroblasts by HILIC-ESI-MS/MS: Preliminary Findings.Int J Mol Sci. 2019 Jul 7;20(13):3341. doi: 10.3390/ijms20133341. Int J Mol Sci. 2019. PMID: 31284683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
